Economics, Pharmaceutical
"Economics, Pharmaceutical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))
| Descriptor ID |
D017850
|
| MeSH Number(s) |
N03.219.390
|
| Concept/Terms |
Pharmacy Economics- Pharmacy Economics
- Economic, Pharmacy
- Economics, Pharmacy
- Pharmacy Economic
|
Below are MeSH descriptors whose meaning is more general than "Economics, Pharmaceutical".
Below are MeSH descriptors whose meaning is more specific than "Economics, Pharmaceutical".
This graph shows the total number of publications written about "Economics, Pharmaceutical" by people in this website by year, and whether "Economics, Pharmaceutical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Economics, Pharmaceutical" by people in Profiles.
-
Cooper C, Brown A, Court R, Schauberger U, Pizzi L, Willke R. A technical review of the ISPOR Presentations Database: an update on changes to the database from the authors and ISPOR. Int J Technol Assess Health Care. 2023 Jan 24; 39(1):e8.
-
Pizzi LT, Onukwugha E, Corey R, Albarmawi H, Murray J. Competencies for Professionals in Health Economics and Outcomes Research: The ISPOR Health Economics and Outcomes Research Competencies Framework. Value Health. 2020 09; 23(9):1120-1127.
-
Bielory L, Syed BA. Pharmacoeconomics of anterior ocular inflammatory disease. Curr Opin Allergy Clin Immunol. 2013 Oct; 13(5):537-42.
-
Wilt TJ, Qaseem A. Implementing high-value, cost-conscious diabetes mellitus care through the use of low-cost medications and less-intensive glycemic control target. Arch Intern Med. 2012 Nov 12; 172(20):1610-1.
-
Pizzi L, Singh V. Pharmacoeconomics is coming of age. Clin Pharmacol Ther. 2008 Aug; 84(2):188-90.
-
Stefanacci RG. Current implications for the managed care of dementia. Am J Manag Care. 2007 Dec; 13 Suppl 8:S203-5; discussion S206-7.
-
Stefanacci RG, Cafiero AC. Antidementia agents: what is important in this class. Manag Care. 2005 May; 14(5 Suppl):11-6.
-
Maio V, Lofland JH. Outcome measures for pharmacoeconomics education. Pharmacoeconomics. 2004; 22(8):549-50.
-
Bielory L. Update on ocular allergy treatment. Expert Opin Pharmacother. 2002 May; 3(5):541-53.
-
Chalfin DB. Pharmacoeconomic investigations in intensive care. Curr Opin Crit Care. 2001 Dec; 7(6):460-3.